WO2011107922A3 - Extended release composition of milnacipran - Google Patents
Extended release composition of milnacipran Download PDFInfo
- Publication number
- WO2011107922A3 WO2011107922A3 PCT/IB2011/050830 IB2011050830W WO2011107922A3 WO 2011107922 A3 WO2011107922 A3 WO 2011107922A3 IB 2011050830 W IB2011050830 W IB 2011050830W WO 2011107922 A3 WO2011107922 A3 WO 2011107922A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- milnacipran
- extended release
- release composition
- preparation
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Abstract
The present invention relates to an extended release composition comprising milnacipran or its pharmaceutically acceptable salts for oral administration, and process for their preparation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN481/DEL/2010 | 2010-03-04 | ||
IN481DE2010 | 2010-03-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011107922A2 WO2011107922A2 (en) | 2011-09-09 |
WO2011107922A3 true WO2011107922A3 (en) | 2012-04-26 |
Family
ID=44169177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2011/050830 WO2011107922A2 (en) | 2010-03-04 | 2011-02-25 | Extended release composition of milnacipran |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011107922A2 (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008495A1 (en) * | 1996-08-28 | 1998-03-05 | Pierre Fabre Medicament | Galenic formula with extended release of milnacipran |
WO2004037190A2 (en) * | 2002-10-25 | 2004-05-06 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
WO2004039361A1 (en) * | 2002-10-25 | 2004-05-13 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
WO2004067039A1 (en) * | 2003-01-28 | 2004-08-12 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
EP1600156A2 (en) * | 2003-03-05 | 2005-11-30 | Osmotica Corp. | Combination treatment for impaired motor function in parkinson's disease |
WO2005117872A2 (en) * | 2004-06-04 | 2005-12-15 | Dynogen Pharmaceuticals, Inc. | Dual acting snri-nmda antagonists for the treatment of genitourinary disorders |
EP1655029A1 (en) * | 2003-07-25 | 2006-05-10 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal compositions |
US20100040680A1 (en) * | 2008-08-15 | 2010-02-18 | Felix Lai | Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation |
WO2010129689A1 (en) * | 2009-05-05 | 2010-11-11 | Forest Laboratories Holdings Limited | Milnacipran formulations |
WO2011016057A2 (en) * | 2009-08-05 | 2011-02-10 | Lupin Limited | Controlled release pharmaceutical compositions of milnacipran |
-
2011
- 2011-02-25 WO PCT/IB2011/050830 patent/WO2011107922A2/en active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008495A1 (en) * | 1996-08-28 | 1998-03-05 | Pierre Fabre Medicament | Galenic formula with extended release of milnacipran |
WO2004037190A2 (en) * | 2002-10-25 | 2004-05-06 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
WO2004039361A1 (en) * | 2002-10-25 | 2004-05-13 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
WO2004067039A1 (en) * | 2003-01-28 | 2004-08-12 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
EP1600156A2 (en) * | 2003-03-05 | 2005-11-30 | Osmotica Corp. | Combination treatment for impaired motor function in parkinson's disease |
EP1655029A1 (en) * | 2003-07-25 | 2006-05-10 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal compositions |
WO2005117872A2 (en) * | 2004-06-04 | 2005-12-15 | Dynogen Pharmaceuticals, Inc. | Dual acting snri-nmda antagonists for the treatment of genitourinary disorders |
US20100040680A1 (en) * | 2008-08-15 | 2010-02-18 | Felix Lai | Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation |
WO2010129689A1 (en) * | 2009-05-05 | 2010-11-11 | Forest Laboratories Holdings Limited | Milnacipran formulations |
WO2011016057A2 (en) * | 2009-08-05 | 2011-02-10 | Lupin Limited | Controlled release pharmaceutical compositions of milnacipran |
Also Published As
Publication number | Publication date |
---|---|
WO2011107922A2 (en) | 2011-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012021715A3 (en) | Stable formulations of linaclotide | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
IL223783B (en) | Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament | |
IL224288A (en) | Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof | |
WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
WO2011057262A3 (en) | Treatment of infections with tp receptor antagonists | |
WO2012068441A3 (en) | Intedanib salts and solid state forms thereof | |
PL2562172T3 (en) | Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses | |
WO2011104652A3 (en) | Veterinary compositions | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2011141488A3 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2011101863A3 (en) | Extended release pharmaceutical compositions of lacosamide | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
WO2011079193A3 (en) | Preparation of bendamustine and its salts | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
WO2011037976A3 (en) | Pramipexole pharmaceutical formulations | |
MX2012001691A (en) | Orally disintegrating compositions of linaclotide. | |
PT2504331E (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
WO2012029074A3 (en) | Pharmaceutical compositions of linezolid | |
WO2011139249A3 (en) | Pharmaceutical composition comprising cefdinir | |
WO2010148314A3 (en) | Preparation of esomeprazole and its pharmaceutically acceptable salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11713059 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11713059 Country of ref document: EP Kind code of ref document: A2 |